Published in J Virol on April 01, 1982
The distribution of tau in the mammalian central nervous system. J Cell Biol (1985) 7.47
Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc Natl Acad Sci U S A (1984) 2.32
Critical epitopes in transmissible gastroenteritis virus neutralization. J Virol (1986) 2.05
Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol (1987) 1.98
Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J Virol (1988) 1.91
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci U S A (2013) 1.75
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants. J Virol (1985) 1.66
Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J Virol (1983) 1.41
Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6. J Virol (2001) 1.35
Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product. J Virol (1985) 1.28
Antigenicity, function, and conformation of synthetic oligopeptides corresponding to amino-terminal sequences of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1988) 1.14
Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1. J Virol (1984) 1.12
Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: analysis in a viral model. Proc Natl Acad Sci U S A (1986) 1.04
Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization. J Virol (1984) 0.93
Site-specific maturation of enveloped viruses in L cells treated with cytochalasin B. J Cell Biol (1985) 0.92
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56
A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology (1956) 6.41
The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J Virol (1972) 4.04
Lipid composition of purified vesicular stomatitis viruses. J Virol (1971) 3.25
Antibody affinity. 3. The role of multivalance. Immunochemistry (1972) 2.74
Serological relationships between different strains of vesicular stomatis virus. J Gen Virol (1972) 2.68
Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. Virology (1976) 2.09
Studies on the interactions of poliomyelitis virus, antibody, and host cells in tissue culture system. Virology (1958) 2.08
Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. J Gen Virol (1980) 1.96
Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin. Proc Natl Acad Sci U S A (1966) 1.84
Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components. J Virol (1975) 1.77
THE INTERACTION BETWEEN VIRUS AND ANTIBODY. I. KINETIC STUDIES. Virology (1963) 1.59
Reconstitution into liposomes of the glycoprotein of vesicular stomatitis virus by detergent dialysis. J Biol Chem (1979) 1.48
A multi-hit model for the neutralization of animal viruses. J Gen Virol (1978) 1.41
The neutralization of arboviruses. II. Neutralization in heterologous virus-serum mixtures with four group B arboviruses. Virology (1965) 1.21
Immunological basis of the adenovirus 8-9 cross-reaction. J Virol (1970) 1.19
Virus sensitization. Curr Top Microbiol Immunol (1972) 1.17
THE INTERACTION OF NEWCASTLE DISEASE VIRUS AND NEUTRALIZING ANTIBODY. Virology (1965) 1.11
Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization. Science (1981) 1.07
Serological characterization of the three major proteins of vesicular stomatitis virus. J Virol (1974) 1.05
The role of sensitizing antibody in the neutralization of equine arteritis virus by complement or anti-IgG serum. Virology (1973) 0.88
Infectious antibody-reovirus complexes. Infect Immun (1972) 0.85
Studies on the nonneutralizable fraction of poliovirus. Virology (1972) 0.83
Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus. J Mol Biol (1966) 6.61
Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties. Virology (1966) 6.37
Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions. J Virol (1972) 5.93
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
The antigenic structure of proteins: a reappraisal. Annu Rev Immunol (1984) 5.31
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Structural proteins of vesicular stomatitis viruses. J Virol (1969) 4.70
Protein composition of the structural components of vesicular stomatitis virus. J Virol (1969) 4.54
The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J Virol (1972) 4.04
Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J Virol (1979) 3.54
Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference. Virology (1966) 3.49
L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus. J Virol (1973) 3.26
Lipid composition of purified vesicular stomatitis viruses. J Virol (1971) 3.25
Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin. J Virol (1984) 3.18
Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation. J Virol (1977) 2.77
Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46
Carbohydrate composition of vesicular stomatitis virus. J Virol (1971) 2.40
Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci U S A (1965) 2.37
Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus. J Virol (1972) 2.37
Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1995) 2.23
Protein kinase and phosphoproteins of vesicular stomatitis virus. J Virol (1974) 2.11
Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins. J Virol (1971) 2.05
Structure of the amino terminus of a gap junction protein. Arch Biochem Biophys (2000) 2.05
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol (1987) 1.98
Localization of membrane-associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents. J Virol (1980) 1.89
Association of vesicular stomatitis virus glycoprotein with virion membrane: characterization of the lipophilic tail fragment. J Virol (1975) 1.88
Ribonucleic acid species of intracellular nucleocapsids and released virions of vesicular stomatitis virus. J Virol (1972) 1.86
Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies. J Virol (1986) 1.78
Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components. J Virol (1975) 1.77
Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J Virol (1989) 1.73
Role of matrix protein in assembling the membrane of vesicular stomatitis virus: reconstitution of matrix protein with negatively charged phospholipid vesicles. Biochemistry (1981) 1.71
Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology (1966) 1.67
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants. J Virol (1985) 1.66
Sialoglycoprotein of vesicular stomatitis virus: role of the neuraminic acid in infection. J Virol (1974) 1.63
Action of interferon: kinetics and differential effects on viral functions. J Virol (1970) 1.63
The plus-strand leader RNA of VSV inhibits DNA-dependent transcription of adenovirus and SV40 genes in a soluble whole-cell extract. Cell (1982) 1.61
Glycoprotein biosynthesis. Incorporation of glycosyl groups into endogenous acceptors in a Golgi apparatus-rich fraction of liver. J Biol Chem (1971) 1.60
Location of the transcription defect in group I temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1974) 1.58
Mosquito cells infected with vesicular stomatitis virus yield unsialylated virions of low infectivity. J Virol (1975) 1.57
Synthesis of the alpha-1-glycoprotein (Darcy) of rat serum by the liver. Nature (1965) 1.56
Evidence for specific suppression in the maintenance of immunologic tolerance. J Exp Med (1975) 1.55
Differential inhibition of host protein synthesis in L cells infected with RNA - temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1976) 1.55
Enveloped viruses as model membrane systems: microviscosity of vesicular stomatitis virus and host cell membranes. Biochemistry (1976) 1.54
Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus. J Virol (1978) 1.51
Reconstitution into liposomes of the glycoprotein of vesicular stomatitis virus by detergent dialysis. J Biol Chem (1979) 1.48
Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J Virol (1995) 1.46
Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule. Infect Immun (1984) 1.45
Reversible inhibition of interferon synthesis by puromycin: evidence for an interferon-specific messenger RNA. Proc Natl Acad Sci U S A (1965) 1.44
RNA- temperature-sensitive mutants of vesicular stomatitis virus: L-protein thermosensitivity accounts for transcriptase restriction of group I mutants. J Virol (1976) 1.44
Use of UV irradiation to identify the genetic information of vesicular stomatitis virus responsible for shutting off cellular RNA synthesis. J Virol (1979) 1.44
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus. J Virol (1994) 1.39
The crystal structure of a major dust mite allergen Der p 2, and its biological implications. J Mol Biol (2002) 1.37
Structural proteins of two salmonid rhabdoviruses. J Virol (1975) 1.36
Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors. J Virol (1988) 1.33
Classification of the New Jersey serotype of vesicular stomatitis virus into two subtypes. J Virol (1978) 1.32
Enzymatic transfer of 14C-glucosamine from UDP-N-acetyl-14C-glucosamine to endogenous acceptors in a Golgi apparatus-rich fraction from liver. Biochem Biophys Res Commun (1969) 1.32
Isolation and partial characterization of a monoclonal antibody to the Rous sarcoma virus transforming protein pp60src. J Virol (1983) 1.31
Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product. J Virol (1985) 1.28
Inhibition of viral transcriptase by immunoglobulin directed against the nucleocapsid NS protein of vesicular stomatitis virus. J Virol (1975) 1.27
The termination of immunological unresponsiveness to bovine serum albumin in rabbits. I. Quantitative and qualitative response to cross-reacting albumins. J Exp Med (1970) 1.24
Influence of the peripheral matrix protein of vesicular stomatitis virus on the membrane dynamics of mixed phospholipid vesicles: fluorescence studies. Biochemistry (1983) 1.23
Inhibition of transcription by immunoglobulins directed against the ribonucleoprotein of homotypic and heterotypic vesicular stomatitis viruses. J Virol (1978) 1.22
Inhibition by aurintricarboxylic acid and polyethylene sulfonate of RNA transcription of vesicular stomatitis virus. J Virol (1975) 1.21
Microviscosity of togavirus membranes studied by fluorescence depolarization: influence of envelope proteins and the host cell. J Virol (1976) 1.21
The occurrence of 4-amino-4-deoxy-L-arabinose as a constituent in Salmonella lipopolysaccharide preparations. Eur J Biochem (1970) 1.20
Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis. J Virol (1979) 1.20
Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid. J Virol (1975) 1.19
Immunochemical detection of an acute-phase protein in rat serum. Am J Physiol (1965) 1.19
Nature, type of linkage, and absolute configuration of (hydroxy) fatty acids in lipopolysaccharides from Xanthomonas sinensis and related strains. J Bacteriol (1975) 1.16
Rabbit macrophage interferons. II. Some physicochemical properties and estimations of molecular weights. J Exp Med (1967) 1.16
Use of antiviral-antiferritin hybrid antibody for localization of viral antigen in plasma membrane. J Virol (1971) 1.15
Global changes in amide hydrogen exchange rates for a protein antigen in complex with three different antibodies. J Mol Biol (1996) 1.14
Antigenicity, function, and conformation of synthetic oligopeptides corresponding to amino-terminal sequences of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1988) 1.14
Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA. J Virol (1983) 1.13
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes. Virology (1987) 1.12
Immune response to the src gene product in mice bearing tumors induced by injection of avian sarcoma virus-transformed mouse cells. J Virol (1979) 1.11
Neonatally induced tolerance to HGG: duration in B cells and absence of specific suppressor cells. J Immunol (1977) 1.10
Viral membranes: model systems for studying biological membranes. CRC Crit Rev Biochem (1979) 1.10
Lipid organization of the membrane of vesicular stomatitis virus. J Biol Chem (1978) 1.10
Nucleotide sequence and secondary structure of VSV leader RNA and homologous DNA involved in inhibition of DNA-dependent transcription. Cell (1984) 1.10
Reversal by certain polyanions of an endogenous inhibitor of the vesicular stomatitis virus-associated transcriptase. J Biol Chem (1978) 1.09
Trichophyton antigens associated with IgE antibodies and delayed type hypersensitivity. Sequence homology to two families of serine proteinases. J Biol Chem (1998) 1.08
Effect of phospholipase C and cholesterol oxidase on membrane integrity, microviscosity, and infectivity of vesicular stomatitis virus. Biochemistry (1977) 1.08
Isolation and identification of N-acetyl-3-amino-3,6-dideoxy-D-galactose, a cell wall constituent of Xanthomonas campestris. J Biol Chem (1965) 1.08
The incorporation of 14C-glucosamine from UDP-N-acetyl-14C-glucosamine into liver microsomal protein in vitro. Arch Biochem Biophys (1969) 1.07
Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses. Intervirology (1979) 1.07
Glycoprotein micelles isolated from vesicular stomatitis virus spontaneously partition into sonicated phosphatidylcholine vesicles. Virology (1980) 1.07
Quantitative assay of polysaccharide components obtained from cell wall lipopolysaccharides of Xanthomonas species. J Bacteriol (1968) 1.05
Adenosine-5'-O-(3-thiotriphosphate) as an affinity probe for studying leader RNA's transcribed by vesicular stomatitis virus. J Biol Chem (1979) 1.05
Inhibition of cellular DNA synthesis by vesicular stomatitis virus. J Virol (1981) 1.04
Transcription inhibition site on the M protein of vesicular stomatitis virus located by marker rescue of mutant tsO23(III) with M-gene expression vectors. J Virol (1989) 1.04
Envelope proteins of vesicular stomatitis virions: accessibility to iodination. Virology (1974) 1.04
Site-specific mutations in vectors that express antigenic and temperature-sensitive phenotypes of the M gene of vesicular stomatitis virus. J Virol (1988) 1.03
Glycoprotein metabolism: a UDP-galactose-glycoprotein galactosyltransferase of rat serum. Biochem Biophys Res Commun (1971) 1.02
Pyrene phospholipid as a biological fluorescent probe for studying fusion of virus membrane with liposomes. Biochemistry (1988) 1.02